- The Biden administration is being pressured to suspend the intellectual property of companies that have developed the COVID-19 vaccine and antibody therapies.
- The intellectual property possessed by companies that helped them develop a COVID-19 vaccine as well as antibody therapies offer means to develop vaccines and therapies to address future virus variants.
- Suspending the IP will not lead to more vaccinations across the globe with better results. Instead, they will likely create a different set of complex problems.
For further details see:
Operation Warped Screed: The Government Threatens To Suspend The COVID Vaccine Intellectual Property